[1] Aboutalebi A, Korman JB, Sohani AR, et al. Aleukemic cutaneous myeloid sarcoma. J Cutan Pathol. 2013;40(12):996-1005.
[2] Bain EE, Rothman I, Lin L. De novo myeloid sarcoma in a 4-month-old infant: a case report and review of the literature. J Cutan Pathol. 2013;40(3):321-325.
[3] Clark WB, Strickland SA, Barrett AJ, Savani BN. Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. Haematologica. 2010;95(6):860-863.
[4] Byrd JC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol. 1995;13(7):1800-1816.
[5] Klco JM, Welch JS, Nguyen TT, et al. State of the art in myeloid sarcoma. Int J Lab Hematol. 2011;33(6):555-565.
[6] Wang JF, O’Malley DP. Extramedullary acute leukemia developing in a pre-existing osteoma cutis. J Cutan Pathol. 2014;41(7):606-611.
[7] Bakst RL, Tallman MS, Douer D, Yahalom J. How I treat extramedullary acute myeloid leukemia. Blood. 2011;118(14):3785-3793.
[8] Falini B, Lenze D, Hasserjian R, et al. Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia. 2007;21(7):1566-1570.
[9] Ansari-Lari MA, Yang CF, Tinawi-Aljundi R, et al. FLT3 mutations in myeloid sarcoma. Br J Haematol. 2004;126(6):785-791.
[10] Yuchieh L, Xixue C, Yang W. Generalized Asymptomatic Skin Nodules in a Young Man. JAMA Oncol. Published online January 28, 2021.
